Test Numbers 982929A Novartis Financial Results – Q3 2025 Novartis announces the company’s financial results for the third quarter of 2025. 92A71H1 Manufacturing expansion in the United States Novartis is expanding our manufacturing and R&D facilities in the US to scale innovation, help patients and create jobs.